Andrew Simon

Andrew Simon

AbbVie Showcases New Analyses and Real-World Data Across Multiple Immune-Mediated Skin Diseases at the European Academy of Dermatology and Venereology (EADV) 2022 Congress

Analyses highlight long-term efficacy and safety results, including real-world data, from studies of SKYRIZI® (risankizumab) in moderate to severe psoriasis and active psoriatic arthritis Presentations include data from the largest-of-its-kind study that demonstrates the real-world burden of atopic dermatitis Breadth of data…